Sun Pharma Unit Caraco launches anti- cancer drug in US
Products
Monday, 15 March 2010 00:00
Oxaliplatin is equivalent to Sanofi-Aventis' Eloxatin and used to treat colon and rectal cancer, Caraco said in a statement. Oxaliplatin injections have annual sales of about $1.3 billion in the US market, it said.